Income Tax Expense

12 Months Ended

Mar. 31, 2026

NOTE 12 — INCOME TAX EXPENSE

	2026		2025		2024
Hong Kong enterprises income tax:
Current tax	$	7,666	$	63,168	$	196,252
Deferred tax		—		—		—
Total	$	7,666	$	63,168	$	196,252

Cellyan Biotechnology Co., Ltd was incorporated in the Cayman Islands, and, under the current laws of the Cayman Islands, is not subject to income taxes.

The tax charge for the Group can be divided into Hong Kong entities and PRC entity. Both Hong Kong entities and PRC entity are operating entities and may be subject to income tax and deferred tax.

Hong Kong

On March 21, 2018, the Hong Kong Legislative Council passed The Inland Revenue (Amendment) (No. 7) Bill 2017 (the “Bill”) which introduces the two-tiered profits tax rates regime. The Bill was signed into law on March 28, 2018 and was announced on the following day. Under the two-tiered profits tax rates regime, the first 2 million Hong Kong Dollar (“HKD”) of profits of the qualifying group entity will be taxed at 8.25%, and profits above HKD2 million will be taxed at 16.5%.

The following table reconciles the statutory rate to the Company’s effective tax rate for the years ended March 31, 2026, 2025 and 2024:

	2026			2025			2024
Hong Kong Statutory income tax rate		16.5	%		16.5	%		16.5	%
Permanent difference for non-deductible expense		-	%		44.8	%		0.6	%
Permanent difference for non-taxable income		(0.6	)%		(2.0	)%		(0.6	)%
Deferred tax not provided for		(1.1	)%		(11.2	)%		(0.2	)%
Previous years’ operating loss deducted in current year		-	%		-	%		(0.7	)%
Effect of Hong Kong preferential tax rate		0.6	%		(59.7	)%		(2.8	)%
Effect of different tax jurisdiction		(16.1	)%		186.5	%		0	%
Effective tax rate		(0.7	)%		174.9	%		12.8	%